Kana Lessig Stemsoft Software -

Manually tracking these data points—from collection to apheresis, manufacturing, and final infusion—leads to inefficiencies and potential risks. Streamlining Compliance with Configurable Informatics

The field of cellular therapy is moving at breakneck speed. CAR-T, IEC, and other advanced therapy medicinal products (ATMPs) are revolutionizing patient care, transforming how we treat cancer and other diseases. Yet, with this incredible innovation comes a complex reality: managing the data of human cells as a raw material requires unprecedented precision.

At STEMSOFT, we believe in "Scientists Helping Scientists." With nearly three decades of experience, we provide in-house expertise and a dedicated support team to ensure your informatics solutions evolve alongside your science. Kana Lessig Stemsoft Software

If you can provide more context on the source of the name "Kana Lessig," I can try to refine this search. Otherwise, I can:

Manufacturing and administering advanced therapies requires complete, accurate, and detailed records. Whether you are a cord blood bank, a public marrow transplant center, or a commercial cell therapy manufacturer, the regulatory landscape is constantly evolving, requiring strict adherence to FACT/JACIE, AABB, cGMP, and cGTP standards. Yet, with this incredible innovation comes a complex

(e.g., a case study or press release).

Learn more about STEMSOFT’s solutions to take control of your data today. we empower providers to:

STEMSOFT provides the industry's leading cellular therapy software solutions, designed specifically to manage this complexity. By offering comprehensive informatics solutions that focus on end-to-end information management, we empower providers to: